TYRA - NASDAQ

Tyra Biosciences, Inc.

TYRA·NASDAQ

$28.69

-5.3%

HealthcareBiotechnology

Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The company is also developing programs targeting FGFR2- intrahepatic cholangiocarcinoma,FGFR3-related achondroplasia, REarranged during transfection kinase, and FGFR4-related cancers. In addition, the company offers SNAP platform which enable rapid structural design through iterative molecular SNAPshots. Tyra Biosciences, Inc. was incorporated in 2018 and is based in Carlsbad, California.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$1.71B

EPS-2.0100

P/E Ratio-13.06

Earnings Date08/06/2026

tyra

Other Current Liabilities

Last Annual Value

16.44M

3-Year CAGR

5-Year CAGR

126%

10-Year CAGR

14%

Adjust for Inflation

Tyra Biosciences, Inc. Competitors Analysis of Other Current Liabilities

TYRA · NASDAQ

Company	Other Current Liabilities	CAGR 3Y	CAGR 5Y	CAGR 10Y
Tyra Biosciences, Inc. NASDAQ:TYRA	16.44M	46.1%	N/A	N/A
Savara Inc. NASDAQ:SVRA	8.08M	25.9%	N/A	67.3%
ProKidney Corp. NASDAQ:PROK	29.80M	58.2%	N/A	N/A
Kura Oncology, Inc. NASDAQ:KURA	110.44M	103.3%	69.4%	N/A
Prime Medicine, Inc. NASDAQ:PRME	12.60M	4.9%	-3.0%	N/A
Rezolute, Inc. NASDAQ:RZLT	2.27M	37.0%	96.7%	35.5%
Maravai LifeSciences Holdings, Inc. NASDAQ:MRVI	39.48M	-6.1%	15.9%	N/A
EyePoint Pharmaceuticals, Inc. NASDAQ:EYPT	2.14M	-45.6%	-21.8%	-1.9%
Geron Corporation NASDAQ:GERN	80.84M	80.4%	58.4%	N/A
Day One Biopharmaceuticals, Inc. NASDAQ:DAWN	54.62M	46.5%	250.0%	N/A

Tyra Biosciences, Inc. Fair Value Envelope

TYRA · NASDAQ

Our analysis suggests that TYRA has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $28.69, this represents a potential HIDDEN relative to our calculated worth for Tyra Biosciences, Inc..

HIDDEN

Intrinsic Value

Current Price: $28.69

Related Guides

Blog Categories

Continue your TYRA research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.